InvestorsObserver
×
News Home

Concert Pharmaceuticals Inc (CNCE) is down 3.00% Friday In Premarket Trading

Friday, November 05, 2021 08:04 AM | InvestorsObserver Analysts

Mentioned in this article

Concert Pharmaceuticals Inc (CNCE) is down 3.00% Friday In Premarket Trading

Concert Pharmaceuticals Inc (CNCE) is down -3.00%% today.

Overall Score - 43
CNCE has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on CNCE!
CNCE stock closed at $3.67 and is down -$0.11 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CNCE has a roughly average overall score of 43 meaning the stock holds a better value than 43% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. CNCE gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Concert Pharmaceuticals Inc currently has the 139th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders. Concert Pharmaceuticals Inc's Overall and Short-Term Technical score paint a mixed picture for CNCE's recent trading patterns and forecasted price. Click Here To Get The Full Report on Concert Pharmaceuticals Inc (CNCE)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App